Shibusawa, M., Tanimoto, T. (2026). Quizartinib for Newly Diagnosed
                    <i>FLT3</i>
                    -Internal Tandem Duplication–Negative AML. Journal of Clinical Oncology. https://doi.org/10.1200/jco-25-02702